Against the backdrop of the US opioid epidemic, clinicians, hospitals, lawmakers, and the public are very concerned about the role of opioids in pain management. Although the majority of today’s opioid overdose deaths involve heroin, illicit fentanyl, and polypharmacy [2], it is undeniable that reckless overprescribing helped fuel today’s crisis [5]. As a result, a common question is: how can we reduce opioid prescribing? Or in the language of Toward Opioid-Free Arthroplasty: A Leadership Forum, the June 2018 gathering that inspired this special issue of HSS Journal, which I attended (Fig. 1): how do we move toward “opioid-free” medicine—in this case, opioid-free arthroplasty?
×
…
Anzeige
Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten